Drug Monitoring

"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor ID	D016903
MeSH Number(s)	E01.370.520.200
Concept/Terms	Drug Monitoring Drug Monitoring Monitoring, Drug Therapeutic Drug Monitoring Therapeutic Drug Monitoring Drug Monitoring, Therapeutic Monitoring, Therapeutic Drug

Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Monitoring, Physiologic [E01.370.520]
Drug Monitoring [E01.370.520.200]

Below are MeSH descriptors whose meaning is related to "Drug Monitoring".

Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.

Bar chart showing 13 publications over 9 distinct years, with a maximum of 3 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2004	1	0	1
2009	0	1	1
2011	2	1	3
2012	1	1	2
2014	2	0	2
2015	1	0	1
2018	0	1	1
2020	1	0	1

Below are the most recent publications written about "Drug Monitoring" by people in Profiles.

Alonso-Padilla J, Abril M, Alarc?n de Noya B, Almeida IC, Angheben A, Araujo Jorge T, Chatelain E, Esteva M, Gasc?n J, Grijalva MJ, Guhl F, Hasslocher-Moreno AM, L?pez MC, Luquetti A, Noya O, Pinazo MJ, Ramsey JM, Ribeiro I, Ruiz AM, Schijman AG, Sosa-Estani S, Thomas MC, Torrico F, Zrein M, Picado A. Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. PLoS Negl Trop Dis. 2020 04; 14(4):e0008035.

View in: PubMed
Min S, Papaz T, Lafreniere-Roula M, Nalli N, Grasemann H, Schwartz SM, Kamath BM, Ng V, Parekh RS, Manlhiot C, Mital S. A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation. Pediatr Transplant. 2018 11; 22(7):e13285.

View in: PubMed
Han J, Saraf SL, Lash JP, Gordeuk VR. Use of anti-inflammatory analgesics in sickle-cell disease. J Clin Pharm Ther. 2017 Oct; 42(5):656-660.

View in: PubMed
Carris NW, Hwang AY, Smith SM, Taylor JR, Sando K, Powell J, Rosenberg EI, Zumberg MS, Gums JG, Dietrich EA, Anderson KV. Patient satisfaction with extended-interval warfarin monitoring. J Thromb Thrombolysis. 2016 Nov; 42(4):486-93.

View in: PubMed
Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, L?pez OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C, Marquet P. Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Ther Drug Monit. 2016 Apr; 38(2):143-69.

View in: PubMed
Mojtahedzadeh M, Lee ML, Friedman TC. Continuation or discontinuation of pioglitazone when starting bedtime insulin in patients with poorly controlled type 2 diabetes in an inner-city population. J Diabetes Complications. 2015 Nov-Dec; 29(8):1248-52.

View in: PubMed
Carris NW, Spinelli A, Pierini D, Taylor JR, Anderson KV, Sando K, Powell J, Rosenberg EI, Zumberg MS, Smith SM, Gums JG, Dietrich E. Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin. Cardiovasc Ther. 2015 Jun; 33(3):98-103.

View in: PubMed
Mercolini L, Mandrioli R, Protti M, Conca A, Albers LJ, Raggi MA. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients. Bioanalysis. 2014 Jun; 6(11):1487-95.

View in: PubMed
Davis J, Chavez B, Juarez DT. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study. Ann Pharmacother. 2014 Jan; 48(1):41-7.

View in: PubMed
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013 Apr; 56(7):1004-17.

View in: PubMed

People

Explore

Similar Concepts

Top Journals